Huayi Feng

机构：Suzhou Traditional Chinese Medicine Hospital · ORCID：0000-0003-3440-6706

发表论文 29 篇 · 总被引 302 次 · h-index 10

代表论文

• Incidence of Death From Unintentional Injury Among Patients With Cancer in the United States (2020 · JAMA Network Open · 被引 37)
• ALKBH5-mediated upregulation of CPT1A promotes macrophage fatty acid metabolism and M2 macrophage polarization, facilitating malignant progression of colorectal cancer (2024 · Experimental Cell Research · 被引 36)
• FGL1 as a Novel Mediator and Biomarker of Malignant Progression in Clear Cell Renal Cell Carcinoma (2021 · Frontiers in Oncology · 被引 36)
• FDX1 expression predicts favourable prognosis in clear cell renal cell carcinoma identified by bioinformatics and tissue microarray analysis (2022 · Frontiers in Genetics · 被引 30)
• SPI1 is a prognostic biomarker of immune infiltration and immunotherapy efficacy in clear cell renal cell carcinoma (2022 · Discover Oncology · 被引 19)
• Loss of cell division cycle‑associated 5 promotes cell apoptosis by activating DNA damage response in clear cell renal cell carcinoma (2022 · International Journal of Oncology · 被引 18)